The long-term effects of Caverta 100 mg (which contains Sildenafil, the active ingredient in Viagra) are generally studied and reviewed by various health authorities and medical organizations. These reviews are typically conducted by:
Pharmaceutical Companies: The manufacturers of Caverta (usually pharmaceutical companies) conduct clinical trials and long-term studies on the drug's safety and effectiveness. Their findings are submitted to regulatory bodies for approval.
Regulatory Agencies: Authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other national health organizations review long-term studies on the drug before it is approved for use and may continue monitoring its effects after approval through post-marketing surveillance.
Academic and Clinical Research Institutions: Independent medical researchers and academic institutions publish studies in peer-reviewed journals on the long-term safety and side effects of medications like Caverta 100mg. These studies often focus on specific health conditions, populations, or interactions.
Healthcare Providers: Doctors and other healthcare professionals who prescribe Caverta may also contribute to understanding its long-term effects by tracking patient outcomes and reporting adverse events to regulatory bodies.
Post-marketing Surveillance: After the drug is released, pharmacovigilance programs monitor the ongoing safety and effectiveness of Caverta based on real-world use. This includes reporting from patients and healthcare providers about any adverse events or side effects.
If you’re interested in specific studies or concerns regarding Caverta’s long-term effects, you could look up clinical trials or research articles on platforms like PubMed, or consult with a healthcare provider for the most up-to-date and personalized information.
Add your comment